Global stem cell UCB market to grow at a CAGR of 30.36% over the period 2014-2019

1
Global Stem Cell Umbilical Cord Blood (UCB)
Market 2015-2019
2
Report Description
About Stem Cell UCB UCB is the blood that remains
in the placenta and the attached umbilical cord
after childbirth. UCB contains stem cells that
are unique, smart, and are capable of treating
several life-threatening diseases. They are used
in the treatment of hematopoietic and genetic
disorders. The placental blood can produce 10
times more quantity of stem cells compared to the
umbilical cord, which can in turn be used for the
treatment of an adult patient. The cord blood
that is collected during the childbirth is stored
and cryopreserved. The storage of the cord blood
can be done at private cord blood banks or public
cord blood banks. This preserved blood can be
used for the transplantation, and treatment of
diseases at the later stages of life. Get
complete Report _at_ http//www.bigmarketresearch.com
/global-stem-cell-umbilical-cord-blood-ucb-2015-20
19-market The global stem cell UCB market to
grow at a CAGR of 30.36 over the period
2014-2019. Covered in this Report The report
covers the present scenario and the growth
prospects of the global stem cell UCB market for
the period 2015-2019. To calculate the market
size, the report considers revenue generated from
the banking and utilization of UCB stem cells for
the treatment of various disorders, such as
cancers, blood disorders, metabolic disorders,
immune diseases, and others.
3
Report Description
Global Stem Cell UCB Market 2015-2019, has been
prepared based on an in-depth market analysis
with inputs from industry experts. The report
covers the Americas, APAC, and EMEA it also
covers the landscape of the global stem cell UCB
market and its growth prospects in the coming
years. The report includes a discussion of the
key vendors operating in this market. Key
Regions Americas APAC EMEA Key Vendors
Caladrius Biosciences Celgene Mesoblast
Pluristem Therapeutics Enquire about this report
_at_ http//www.bigmarketresearch.com/report-enquiry/
280090
4
Report Description
Other Prominent Vendors Athersys CHA Bio and
Diostech Cytori Therapeutics Nuo
Therapeutics Ocata Therapeutics Opexa
Therapeutics Osiris Therapeutics Teva
Pharmaceuticals United Therapeutics Key
Market Driver Effective Treatment of
Life-threatening Diseases For a full, detailed
list, view our report Key Market Challenge
Stringent Regulations For a full, detailed
list, view our report
5
Report Description
Key Market Trend Growing Public Awareness For
a full, detailed list, view our report Key
Questions Answered in this Report What will the
market size be in 2019 and what will the growth
rate be? What are the key market trends? What
is driving this market? What are the challenges
to market growth? Who are the key vendors in
this market space? What are the market
opportunities and threats faced by the key
vendors? What are the strengths and weaknesses
of the key vendors?
6
Table of Contents
01. Executive Summary 02. List of
Abbreviations 03. Scope of the Report 04. Market
Research Methodology 05. Introduction 06. Process
of Collection, Processing and Storage of Cord
Blood Cells 07. Facts Cord Blood Units 08. US
FDA Approved Stem Cell UCB Product 09. Pipeline
Analysis 10. Market Landscape 11. Market
Segmentation by Application 12. Market
Segmentation by Storage 13. Harmonization of
Biobanking 14. Market Segmentation by
End-users 15. Geographical Segmentation 16.
Buying Criteria 17. Market Growth Drivers 18.
Drivers and their Impact 19. Market Challenges
7
FOR MORE DETAILS
Visit us at
http//www.bigmarketresearch.com/global-stem-cell-
umbilical-cord-blood-ucb-2015-2019-market
Stay With Us
TELEPHONE [phone] EMAIL
help_at_bigmarketresearch.com
5933 NE Win Sivers Drive,205, Portland, OR
97220United States